Conservative Management on Hidradenitis Supurativa Hurley III Bilateral

Authors

  • I Gusti Agung Ayu Pramasinthya Aguseny Yudana Fakultas Kedokteran Undiksha
  • Bayu Pramana Suryawan Putra
  • Kadek Devi Indah Anggelina
  • Ketut Suteja Wibawa
  • Yufi Aulia Azmi

Keywords:

Hidradenitis suppurativa, Hurley Staging, Conservative Management, Case Report

Abstract

Hidradenitis suppurativa (HS) is a skin disease caused by inflammation of hair follicles, characterized by perifollicular lymphocytic infiltrate followed by recurrent loss of sebaceous glands. Currently, the etiology of HS is still idiopathic; there are predisposing factors that can affect this disease, such as the immune system, hormones, obesity, smoking, and family history. It can cause occlusion and inflammation of hair follicles, which worsens the infection. Based on epidemiology, women are generally the largest population in HS. Hidradenitis suppurativa cases are rare and dependent on the population but can affect the patient's quality of life. Here in, we present a 21-year-old man complaining of pus coming out of both armpits 2 days before going to the clinic. The patient had complained of the same thing 6 years ago and had a history of frequent shaving of armpit hair. General and physical examinations were normal. The obtained dermatologological status shows Hurley grade III hidradenitis suppurativa in the bilateral axilla. This patient was given a conservative management with a combination of oral antibiotics of Rifampicin and Clindamycin for 8 weeks, and fusidic acid as a topical antibiotic, then Paracetamol as an analgesic. After comparing cases and theories, it was found that there were variations in epidemiology and etiology. The first-line conservative management of HS is oral medications and can also involve operative management adjusted to the condition and severity of HS. In this case of Hidradenitis Suppurativa Hurley III Bilateral, it was treated with conservative management and has shown improvement.

References

Saunte DML, Jemec GBE. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. JAMA [Internet]. 2017 Nov 28 [Accessed 2024 Aug 31];318(20):2019–32. Available from: https://pubmed.ncbi.nlm.nih.gov/29183082/

Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61. doi: 10.1111/jdv.16677. Epub 2020 Jul 16. PMID: 32460374

Ingram JR. The epidemiology of hidradenitis suppurativa*. British Journal of Dermatology [Internet]. 2020 Dec 1 [cited 2024 Aug 31];183(6):990–8. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.19435

Collier EK, Parvataneni RK, Lowes MA, Naik HB, Okun M, Shi VY, et al. Diagnosis and management of hidradenitis suppurativa in women. Am J Obstet Gynecol. 2021;224(1):54–61.

Wolk Id K, Join-Lambert Id O, Sabat Id R, Sabat R. Aetiology and pathogenesis of hidradenitis suppurativa Funding sources. British Journal of Dermatology [Internet]. 2020 [cited 2024 Aug 31];183:999–1010. Available from: http://www.bmbf.de

Napolitano M, Megna M, Timoshchuk EA, Patruno C, Balato N, Fabbrocini G, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol [Internet]. 2017 Apr 19 [cited 2024 Aug 31];10:105–15. Available from: https://pubmed.ncbi.nlm.nih.gov/28458570/

Gutierrez E, Issa NT, Resnik B. Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case Report. Journal of Drugs in Dermatology. 2022 Dec 1;21(12):1358–60.

Zhang Y, Yang Y, Zou X. Photodynamic therapy for Hidradenitis Suppurativa/acne inversa: Case report. Photodiagnosis Photodyn Ther [Internet]. 2018 Jun 1 [cited 2024 Oct 10];22:251–2. Available from: https://pubmed.ncbi.nlm.nih.gov/29709603/

Chahine AA, Nahhas AF, Braunberger TL, Rambhatla P V, Hamzavi IH, Detroit B. CASE REPORT Ertapenem rescue therapy in hidradenitis suppurativa. JAAD Case Rep [Internet]. 2018 [cited 2024 Oct 10];4:482–3. Available from: https://doi.org/10.1016/j.jdcr.2017.12.010

Thorlacius L, Theut Riis P, Jemec GBE. Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report. British Journal of Dermatology [Internet]. 2018 Jul 1 [cited 2024 Oct 10];179(1):182–5. Available from: https://dx.doi.org/10.1111/bjd.15769

Huang J, Tsang LSL, Shi W, Li J. Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review. Front Med (Lausanne) [Internet]. 2022 Mar 24 [cited 2024 Oct 10];9. Available from: /pmc/articles/PMC8987973/

Kurokawa I, Kita K, Hashimoto T. Successful treatment of ulceration in hidradenitis suppurativa with topical bucladesine: A case report. Skin Health and Disease [Internet]. 2024 Feb 1 [cited 2024 Oct 10];4(1):e321. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/ski2.321

Harvey LM, Fortson JK. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management. Cureus [Internet]. 2021 Oct 12 [cited 2024 Oct 10];13(10). Available from: /pmc/articles/PMC8584235/

Esme P, Akoglu G, Caliskan E. Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report. Skin Appendage Disorder [Internet]. 2021 [cited 2024 Oct 10];7:58–61. Available from: www.karger.com/sad

Patrut E, Fabian OV, Cozma A, Muntean M, Chir AI, Pătruţ EM, et al. Hidradenitis Suppurativa. A Case Report. Ann Ital Chir [Internet]. 2023 May 8;12:12–20. Available from: https://www.researchgate.net/publication/370844848

MI N. HIDRADENITIS SUPPURATIVA - A CASE REPORT. J West Afr Coll Surg [Internet]. 2011 [cited 2024 Oct 16];1(4):60. Available from: /pmc/articles/PMC4170276/

Santos-Pérez MI, García-Rodicio S, del Olmo-Revuelto MA, Pozo-Román T. Ustekinumab for Hidradenitis Suppurativa: A Case Report. Actas Dermosifiliogr [Internet]. 2014 Sep 1 [cited 2024 Oct 10];105(7):720–2. Available from: http://www.actasdermo.org/es-ustekinumab-for-hidradenitis-suppurativa-a-articulo-S1578219014001711

Laroche ML, Teste M, Vanoost J, Geniaux H. Successful control of hidradenitis suppurativa with verapamil: a case report. Fundam Clin Pharmacol [Internet]. 2019 Feb 1 [cited 2024 Oct 10];33(1):122–4. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/fcp.12403

Alqahtani S. Management of axillary hidradenitis suppurativa: A case report. Int J Health Sci (Qassim). 2023;17(1):61.

Godiwalla R, Storie E, Winn A. Case Report Hidradenitis Suppurativa in the Military. Military Dermatology. 2020;106(4):181–4.

Wolff Klaus, Johnson RAllen, Saavedra AP., Roh Ellen. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 2017;927.

Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis [Internet]. 2021 Nov 1 [cited 2024 Aug 31];12. Available from: https://doi.org/10.1177/20406223211055920https://doi.org/10.1177/20406223211055920

Seyed Jafari SM, Hunger RE, Schlapbach C. Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm. Front Med (Lausanne) [Internet]. 2020 Mar 4 [cited 2024 Aug 31];7. Available from: https://pubmed.ncbi.nlm.nih.gov/32195261/

Caposiena Caro RD, Cannizzaro MV, Botti E, Di Raimondo C, Di Matteo E, Gaziano R, et al. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations. J Am Acad Dermatol [Internet]. 2019 May 1 [cited 2024 Aug 31];80(5):1314–21. Available from: https://pubmed.ncbi.nlm.nih.gov/30502416/

Scheinfeld N. Extensive hidradenitis suppurativa (HS) hurly stage III disease treated with intravenous (IV) linezolid and meropenem with rapid remission. Dermatol Online J [Internet]. 2015 [cited 2024 Oct 10];21(2). Available from: https://escholarship.org/uc/item/42h2744m

Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A Comparison of International Management Guidelines for Hidradenitis Suppurativa. Dermatology [Internet]. 2021 Jan 1 [cited 2024 Aug 31];237(1):81–96. Available from: https://pubmed.ncbi.nlm.nih.gov/31645040/

Menaldi S, Bramono K, Indriatmi W. Ilmu penyakit kulit dan kelamin [Internet]. 7th, Cetakan Keenam ed. Jakarta: Balai Penerbit FKUI; 2019 [cited 2024 Aug 31]. Available from: https://library.fk.ui.ac.id/?p=show_detail&id=25479

Hidayati A, Damayanti, Sari M, Alinda M, Reza N, Anggraeni S, et al. Infeksi Bakteri di Kulit [Internet]. 1st ed. Surabaya: Airlangga University Press; 2019 [cited 2024 Aug 31]. 1 p. Available from: https://books.google.co.id/books/about/Infeksi_Bakteri_di_Kulit.html?id=WyIgEAAAQBAJ&redir_esc=y

Downloads

Published

2025-02-06

How to Cite

Yudana, I. G. A. A. P. A., Bayu Pramana Suryawan Putra, Kadek Devi Indah Anggelina, Ketut Suteja Wibawa, & Yufi Aulia Azmi. (2025). Conservative Management on Hidradenitis Supurativa Hurley III Bilateral. Journal of Medicine & Surgery Case Reports, 1(1), 1–9. Retrieved from https://journal.jmscr.org/jmscr/article/view/6

Issue

Section

Articles